Basel, 19 October 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) will present new data, including two late-breaking abstracts, across lung, breast and other cancers at the 2026 European Society for Medical ...
Rising Liver Cancer Deaths Outpace Other Major Cancers in England and Wales – Liver cancer deaths increased by 26.8% from ...
Three changes show what AI is already doing to everyday care. For someone with diabetes, an automated insulin delivery system ...
Each month, the European Medicines Agency’s human medicines committee (CHMP) weighs in on which drugs should reach European ...
New analysis by Liver Cancer UK of Office for National Statistics (ONS) mortality data has revealed that deaths from liver cancer are rising faster than those from any other major cancer in England ...
Expansion of nebaprubart (JJP-1212) into RA follows positive interim data from its ongoing Phase 1b trial in linear IgA dermatosis (LAD), marking the second indication for the Company’s lead asset and ...
Angelini’s corporate venture arm strengthens its biotech portfolio as Swiss Nouscom advances a potential cancer-prevention ...
GSK Presents First Global Data for Ris-Rez in Extensive-Stage Small Cell Lung Cancer 61% overall response rate in phase Ib ...
REPTILES: Wildlife and Discovery Center of WV sponsors “Reptiles After Dark” from 6 to 8:30 p.m. Thursday, Oct. 22, at 3 ...
Emvistegrast is an investigational once-daily oral therapy designed to selectively inhibit the α4β7 pathway, a clinically validated target in inflammatory bowel disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results